Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2017-10-03 | 2018-03-01 | 24274 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-06-04 | 2021-06-22 | 140420 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-09-16 | 2022-11-26 | 169513 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-05-31 | 2018-08-14 | 50961 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-09-28 | 2023-11-10 | 205489 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-03-02 | 2023-05-06 | 185942 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2024-06-13 | 2024-07-19 | 230489 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-09-28 | 2023-11-10 | 205498 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-09 | 2024-04-26 | 219171 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-02-22 | 2022-03-11 | 155362 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-01-15 | 2020-02-01 | 103370 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-24 | 2021-10-05 | 146157 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-01-06 | 2023-03-02 | 180113 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-04 | 2021-06-14 | 140423 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-04 | 2021-06-14 | 129608 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-01-14 | 2022-02-07 | 152770 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-11 | 2022-10-20 | 166445 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2018-02-21 | 2018-08-09 | 40354 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2022-10-20 | 166601 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-06-23 | 190859 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TICAGRELOR | 60MG | TABLET | Discontinued | 2025-11-19 | 2025-11-20 | 257747 |
| APO-TICAGRELOR | 60MG | TABLET | To be discontinued | 2025-11-12 | 2025-11-20 | 257700 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |